A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Vilazodone in Adolescents with Major Depressive Disorder
Sign Up to like & getrecommendations! Published in 2018 at "Paediatric Drugs"
DOI: 10.1007/s40272-018-0290-4
Abstract: BackgroundMajor depressive disorder (MDD) is a serious illness in children and adolescents. Vilazodone is a selective serotonin reuptake inhibitor approved for MDD in adults. This study evaluated the efficacy, safety, and tolerability of vilazodone in… read more here.
Keywords: study; vilazodone day; placebo; double blind ... See more keywords
Vilazodone-Induced Glycolimia
Sign Up to like & getrecommendations! Published in 2023 at "CNS Spectrums"
DOI: 10.1017/s1092852923001815
Abstract: Abstract Introduction Glycolimia is observed in a plethora of medical conditions including burning mouth syndrome, opioid withdrawal, as well as from a variety of medications including vortioxetine, l-methylfolate, lisdexamfetamine, and gabapentin. While vilazodone, an antidepressant… read more here.
Keywords: glycolimia; day; vilazodone may; vilazodone ... See more keywords
Pediatric ingestion of vilazodone compared to other selective serotonin reuptake inhibitor medications
Sign Up to like & getrecommendations! Published in 2017 at "Clinical Toxicology"
DOI: 10.1080/15563650.2017.1287375
Abstract: Abstract Background: Unintentional ingestion of selective serotonin reuptake inhibitor (SSRI) medications is common amongst children read more here.
Keywords: selective serotonin; serotonin reuptake; age; reuptake inhibitor ... See more keywords
A Randomized, Double-Blind, Placebo-Controlled Trial of Vilazodone in Children and Adolescents with Major Depressive Disorder with Twenty-Six-Week Open-Label Follow-Up
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Child and Adolescent Psychopharmacology"
DOI: 10.1089/cap.2019.0176
Abstract: Objective: To evaluate the efficacy and long-term safety of vilazodone in children and adolescent outpatients with major depressive disorder (MDD). Methods: Children and adolescents aged 7–17 years of age with MDD were randomized 2:2:1 to… read more here.
Keywords: week; depressive disorder; major depressive; placebo ... See more keywords
Comparative evaluation of efficacy and tolerability of vilazodone, escitalopram, and amitriptyline in patients of major depressive disorder: A randomized, parallel, open-label clinical study
Sign Up to like & getrecommendations! Published in 2020 at "Indian Journal of Pharmacology"
DOI: 10.4103/ijp.ijp_441_18
Abstract: OBJECTIVES: To evaluate and compare efficacy and tolerability of Vilazodone with Escitalopram and Amitriptyline in patients of major depressive disorder(MDD). METHODS: This was a randomized, prospective, parallel-group, open label clinical study in which newly diagnosed… read more here.
Keywords: escitalopram amitriptyline; tolerability vilazodone; vilazodone escitalopram; vilazodone ... See more keywords